Shanthi Srinivasan, MD, AGAF
Professor of Medicine, Emory University School of Medicine
Dr. Srinivasan is the co-editor of Gastro Hep Advances, AGA’s newest peer-reviewed journal. She is the new AGA Institute Council Neurogastroenterology & Motility (NGM) section vice chair and is a member of the AGA Institute Council Basic Science Subcommittee. Her clinical interest is in gastrointestinal motility disorders, with a focus on diabetes and how it affects gastrointestinal motility. Dr. Srinivasan will be presenting during two sessions at this year’s meeting.
Get Your Research Published: Tips From the Editors
“How to Get Your Paper Published in Gastro Hep Advances”
- Basic Science
- Education and Training
- Clinical Practice
Date and Time:
Saturday, May 21, 10–11:30 a.m.
This research symposium will cover how to best prepare manuscripts to get accepted for journal publication. Attendees will have the opportunity to ask questions and hear directly from Dr. Srinivasan, co-editor of AGA’s newest peer-reviewed journal Gastro Hep Advances, as well as other AGA journal editors. During Dr. Srinivasan’s presentation, participants will learn more about Gastro Hep Advances. Takeaways will include best practices and practical advice for research published in one of AGA’s journals, which are the top destination for the best basic, clinical and translational research in the field of GI and hepatology, as well as types of manuscripts being accepted and tips for rapid review.
The Gut Microbiota as a Biomarker of Digestive Health, Nutrition and Disease: Ready for Prime Time?
“Gut Microbiota as Biomarkers for Diagnosing and Monitoring Functional GI Disorders”
- Microbiome in Gastrointestinal and Liver Diseases
- Colorectal Diseases
- Liver Diseases and Transplantation
Date and Time:
Monday, May 23, 8–9:30 a.m.
During this translational symposium, Dr. Srinivasan will present on how gut microbial composition and function can be used to detect and predict the course of functional GI disorders. The presentation will cover the current state of the field and what impact microbiome-based diagnostics could have on clinical practice in the near future. Other presenters during this session will discuss microbiome-based diagnostics for inflammatory bowel diseases (IBD) and liver diseases. Attendees will leave with an understanding of the promise and current limitations of incorporating gut microbial testing in clinical practice.